Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Campbell

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Trials|March 3, 2011
Impact on mortality and cancer incidence rates of using random invitation from population registers for recruitment to trialsMatthew Burnell, Aleksandra Gentry-Maharaj, Andy Ryan, et al.
BMJ (Clinical Research Ed.)|November 15, 2008
Recruitment to multicentre trials--lessons from UKCTOCS: descriptive studyUsha Menon, Aleksandra Gentry-Maharaj, Andy Ryan, et al.
Nature|August 12, 2008
Earliest date for milk use in the Near East and southeastern Europe linked to cattle herdingRichard P Evershed, Sebastian Payne, Andrew G Sherratt, et al.
British Journal of Cancer|July 26, 2017
The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)Usha Menon, Alistair J McGuire, Maria Raikou, et al.
Lancet (London, England)|May 15, 2021
Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trialUsha Menon, Aleksandra Gentry-Maharaj, Matthew Burnell, et al.
American Journal of Obstetrics and Gynecology|January 13, 2022
Clinical Opinion: The diagnosis and management of suspected fetal growth restriction: an evidence-based approachChristoph C Lees, Roberto Romero, Tamara Stampalija, et al.
The Journal of Infectious Diseases|March 20, 2026
Genomic Surveillance Reveals Emergence and Spread of Macrolide-Resistant Mycoplasma pneumoniae in Australia During the 2023-2024 EpidemicKingsley King-Gee Tam, Carl J E Suster, Winkie Fong, et al.
The Lancet. Oncology|March 14, 2009
Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)Usha Menon, Aleksandra Gentry-Maharaj, Rachel Hallett, et al.
The Lancet. Oncology|December 15, 2010
Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohortIan Jacobs, Aleksandra Gentry-Maharaj, Matthew Burnell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2015
Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer ScreeningUsha Menon, Andy Ryan, Jatinderpal Kalsi, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Trials|March 3, 2011
Impact on mortality and cancer incidence rates of using random invitation from population registers for recruitment to trialsMatthew Burnell, Aleksandra Gentry-Maharaj, Andy Ryan, et al.
BMJ (Clinical Research Ed.)|November 15, 2008
Recruitment to multicentre trials--lessons from UKCTOCS: descriptive studyUsha Menon, Aleksandra Gentry-Maharaj, Andy Ryan, et al.
Nature|August 12, 2008
Earliest date for milk use in the Near East and southeastern Europe linked to cattle herdingRichard P Evershed, Sebastian Payne, Andrew G Sherratt, et al.
British Journal of Cancer|July 26, 2017
The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)Usha Menon, Alistair J McGuire, Maria Raikou, et al.
Lancet (London, England)|May 15, 2021
Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trialUsha Menon, Aleksandra Gentry-Maharaj, Matthew Burnell, et al.
American Journal of Obstetrics and Gynecology|January 13, 2022
Clinical Opinion: The diagnosis and management of suspected fetal growth restriction: an evidence-based approachChristoph C Lees, Roberto Romero, Tamara Stampalija, et al.
The Journal of Infectious Diseases|March 20, 2026
Genomic Surveillance Reveals Emergence and Spread of Macrolide-Resistant Mycoplasma pneumoniae in Australia During the 2023-2024 EpidemicKingsley King-Gee Tam, Carl J E Suster, Winkie Fong, et al.
The Lancet. Oncology|March 14, 2009
Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)Usha Menon, Aleksandra Gentry-Maharaj, Rachel Hallett, et al.
The Lancet. Oncology|December 15, 2010
Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohortIan Jacobs, Aleksandra Gentry-Maharaj, Matthew Burnell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2015
Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer ScreeningUsha Menon, Andy Ryan, Jatinderpal Kalsi, et al.
Pageof 11